Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
Citi
Healthtrust
Chinese Patent Office
AstraZeneca
McKesson
Deloitte
Harvard Business School
Mallinckrodt

Generated: May 21, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 090568

« Back to Dashboard

NDA 090568 describes ANASTROZOLE, which is a drug marketed by Accord Hlthcare, Apotex Inc, Cipla Ltd, Dr Reddys Labs Ltd, Fresenius Kabi Oncol, Impax Labs Inc, Lannett Co Inc, Mylan, Natco Pharma Ltd, Sandoz, Santos Biotech, Sun Pharm Inds Ltd, Synthon Pharms, Teva Pharms, Watson Labs Teva, West-ward Pharms Int, and Zydus Pharms Usa Inc, and is included in seventeen NDAs. It is available from twenty-nine suppliers. Additional details are available on the ANASTROZOLE profile page.

The generic ingredient in ANASTROZOLE is anastrozole. There are twenty-four drug master file entries for this compound. Thirty suppliers are listed for this compound. Additional details are available on the anastrozole profile page.
Summary for 090568
Tradename:ANASTROZOLE
Applicant:Accord Hlthcare
Ingredient:anastrozole
Patents:0
Therapeutic Class:Antineoplastics
Formulation / Manufacturing:see details
Pharmacology for NDA: 090568
Mechanism of ActionAromatase Inhibitors
Suppliers and Packaging for NDA: 090568
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ANASTROZOLE anastrozole TABLET;ORAL 090568 ANDA Major Pharmaceuticals 0904-6195 N 0904-6195-46
ANASTROZOLE anastrozole TABLET;ORAL 090568 ANDA Accord Healthcare Inc. 16729-035 N 16729-035-10

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength1MG
Approval Date:Jun 28, 2010TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Fuji
Deloitte
Express Scripts
Daiichi Sankyo
Colorcon
Federal Trade Commission
Baxter
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.